WVE

$0.00

(

0.00%

)
Quote details

stock

Wave Life Sciences Ltd

NASDAQ | WVE

8.01

USD

$0.00

(

0.00%

)

At Close (As of Nov 4, 2025)

$1.32B

Market Cap

-

P/E Ratio

-0.8

EPS

$16.73

52 Week High

$5.28

52 Week Low

HEALTHCARE

Sector

WVE Chart

Recent Chart
Price Action

WVE Technicals

Tags:

WVE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $108M
Total Revenue $108M
Cost Of Revenue $8.7M
Costof Goods And Services Sold $8.7M
Operating Income -$110M
Selling General And Administrative $59M
Research And Development $160M
Operating Expenses $219M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.7M
Income Before Tax -$97M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$97M
Comprehensive Income Net Of Tax -
Ebit -$110M
Ebitda -$102M
Net Income -$97M

Revenue & Profitability

Earnings Performance

WVE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $352M
Total Current Assets $320M
Cash And Cash Equivalents At Carrying Value $302M
Cash And Short Term Investments $302M
Inventory -
Current Net Receivables $1.4M
Total Non Current Assets $32M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $17M
Other Non Current Assets -
Total Liabilities $143M
Total Current Liabilities $111M
Current Accounts Payable $16M
Deferred Revenue -
Current Debt -
Short Term Debt $7.6M
Total Non Current Liabilities $32M
Capital Lease Obligations $25M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $25M
Other Current Liabilities $21M
Other Non Current Liabilities -
Total Shareholder Equity $210M
Treasury Stock -
Retained Earnings -$1.1B
Common Stock $1.2B
Common Stock Shares Outstanding $138M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$151M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.7M
Capital Expenditures $938K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$938K
Cashflow From Financing $254M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$97M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $108M
Total Revenue $108M
Cost Of Revenue $8.7M
Costof Goods And Services Sold $8.7M
Operating Income -$110M
Selling General And Administrative $59M
Research And Development $160M
Operating Expenses $219M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.7M
Income Before Tax -$97M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$97M
Comprehensive Income Net Of Tax -
Ebit -$110M
Ebitda -$102M
Net Income -$97M

WVE News

WVE Profile

Wave Life Sciences Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Wave Life Sciences Ltd. is an innovative clinical-stage biotechnology company headquartered in Singapore, focused on developing novel oligonucleotide therapeutics to address serious genetic disorders. Utilizing its proprietary PRISM platform, the company excels in the design and production of stereopure oligonucleotides, which enhance the precision of genetic interventions. Wave’s commitment to addressing unmet medical needs is reflected in its robust pipeline, underscoring its potential as a transformative leader in genetic medicine and its goal of improving patient outcomes on a global scale.

PTLE
+51.53%
$0.28
MSPR
+27.56%
$0.66
SCNX
+15.35%
$0.81
NVDA
-3.95%
$198.69
BYND
-4.31%
$1.33
ORIS
-0.12%
$0.16
PFE
-1.45%
$24.30
VHAI
0.00%
$0.00
HTZ
+36.23%
$6.73
PLTR
-7.93%
$190.74
ASST
-1.57%
$1.25
GRAB
-4.69%
$5.78
INTC
-6.25%
$37.03
PLUG
-8.36%
$2.52
ONDS
-3.08%
$5.96
CHR
+8.10%
$0.13
DNN
-6.16%
$2.74
WTO
-6.22%
$0.04
TSLA
-5.14%
$444.26
CAPT
+31.77%
$0.66
KVUE
-1.05%
$15.97
NFE
+14.40%
$1.35
BITF
-6.56%
$3.84
YDKG
-3.39%
$0.05
EPWK
+3.60%
$0.07
T
-0.36%
$24.44
ETHD
+20.91%
$5.26
F
-1.69%
$12.79
ACHR
-8.25%
$9.56
SOFI
-4.11%
$29.37
AXDX
-61.36%
$0.03
CIFR
-1.09%
$22.51
GPUS
-7.02%
$0.34
HIMS
-3.60%
$42.79
CMBM
+58.82%
$3.24
BTBT
-7.01%
$3.18
BURU
-7.90%
$0.28
AAL
-5.17%
$12.65
NCLH
-15.28%
$18.79
AMD
-3.69%
$250.05
RGTI
-10.07%
$35.18
BTG
-5.88%
$4.00
RIVN
-5.23%
$12.50
CAN
-14.61%
$1.11
AMZN
-1.84%
$249.32
VALE
-2.13%
$11.94
ADAP
-15.14%
$0.05
MARA
-6.68%
$16.62
AAPL
+0.36%
$270.04
UBER
-5.06%
$94.67
TLRY
-5.34%
$1.24
BAC
-0.03%
$53.54
PLTZ
+16.06%
$6.07
SOUN
-11.57%
$15.13
BMNR
-7.93%
$39.46
IREN
-1.65%
$66.63
NOK
-4.75%
$6.81
SNAP
-4.47%
$7.47
WULF
-6.77%
$15.01
VSEE
+3.03%
$1.02
RXRX
-8.08%
$5.00
NIO
-3.50%
$7.16
RUBI
-11.62%
$0.60
WBD
+1.39%
$22.60
NGD
-8.79%
$6.64
CCL
-9.05%
$26.11
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
ADD
-25.47%
$0.05
NVTS
-14.61%
$10.46
RIG
-1.51%
$3.90
QBTS
-10.12%
$29.74
PLTD
+7.99%
$6.35
SRM
+53.27%
$10.30
CMG
+0.72%
$31.74
SMCI
-6.60%
$47.40
VZ
-0.38%
$39.32
DVLT
-3.26%
$1.78
LUMN
-10.90%
$10.54
HPE
-3.83%
$23.56
AMCR
+0.12%
$7.87
KDLY
-11.88%
$0.78
CDE
-8.71%
$13.82
NAKA
-11.88%
$0.78
CLF
-10.02%
$10.68
APLD
-5.50%
$31.06
GOOGL
-2.17%
$277.54
WLGS
-5.57%
$0.04
UUUU
-4.43%
$17.01
CLSK
-6.88%
$16.22
AGNC
+1.29%
$10.18
NVO
-1.75%
$48.25
RR
-8.78%
$4.05
IONZ
+17.01%
$4.47
CGC
-5.83%
$1.12
DENN
+50.36%
$6.18
CTRA
+5.98%
$25.85
FUBO
+6.35%
$3.68
ETWO
0.00%
$3.30
META
-1.62%
$627.32
PTLE
+51.53%
$0.28
MSPR
+27.56%
$0.66
SCNX
+15.35%
$0.81
NVDA
-3.95%
$198.69
BYND
-4.31%
$1.33
ORIS
-0.12%
$0.16
PFE
-1.45%
$24.30
VHAI
0.00%
$0.00
HTZ
+36.23%
$6.73
PLTR
-7.93%
$190.74
ASST
-1.57%
$1.25
GRAB
-4.69%
$5.78
INTC
-6.25%
$37.03
PLUG
-8.36%
$2.52
ONDS
-3.08%
$5.96
CHR
+8.10%
$0.13
DNN
-6.16%
$2.74
WTO
-6.22%
$0.04
TSLA
-5.14%
$444.26
CAPT
+31.77%
$0.66
KVUE
-1.05%
$15.97
NFE
+14.40%
$1.35
BITF
-6.56%
$3.84
YDKG
-3.39%
$0.05
EPWK
+3.60%
$0.07
T
-0.36%
$24.44
ETHD
+20.91%
$5.26
F
-1.69%
$12.79
ACHR
-8.25%
$9.56
SOFI
-4.11%
$29.37
AXDX
-61.36%
$0.03
CIFR
-1.09%
$22.51
GPUS
-7.02%
$0.34
HIMS
-3.60%
$42.79
CMBM
+58.82%
$3.24
BTBT
-7.01%
$3.18
BURU
-7.90%
$0.28
AAL
-5.17%
$12.65
NCLH
-15.28%
$18.79
AMD
-3.69%
$250.05
RGTI
-10.07%
$35.18
BTG
-5.88%
$4.00
RIVN
-5.23%
$12.50
CAN
-14.61%
$1.11
AMZN
-1.84%
$249.32
VALE
-2.13%
$11.94
ADAP
-15.14%
$0.05
MARA
-6.68%
$16.62
AAPL
+0.36%
$270.04
UBER
-5.06%
$94.67
TLRY
-5.34%
$1.24
BAC
-0.03%
$53.54
PLTZ
+16.06%
$6.07
SOUN
-11.57%
$15.13
BMNR
-7.93%
$39.46
IREN
-1.65%
$66.63
NOK
-4.75%
$6.81
SNAP
-4.47%
$7.47
WULF
-6.77%
$15.01
VSEE
+3.03%
$1.02
RXRX
-8.08%
$5.00
NIO
-3.50%
$7.16
RUBI
-11.62%
$0.60
WBD
+1.39%
$22.60
NGD
-8.79%
$6.64
CCL
-9.05%
$26.11
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
ADD
-25.47%
$0.05
NVTS
-14.61%
$10.46
RIG
-1.51%
$3.90
QBTS
-10.12%
$29.74
PLTD
+7.99%
$6.35
SRM
+53.27%
$10.30
CMG
+0.72%
$31.74
SMCI
-6.60%
$47.40
VZ
-0.38%
$39.32
DVLT
-3.26%
$1.78
LUMN
-10.90%
$10.54
HPE
-3.83%
$23.56
AMCR
+0.12%
$7.87
KDLY
-11.88%
$0.78
CDE
-8.71%
$13.82
NAKA
-11.88%
$0.78
CLF
-10.02%
$10.68
APLD
-5.50%
$31.06
GOOGL
-2.17%
$277.54
WLGS
-5.57%
$0.04
UUUU
-4.43%
$17.01
CLSK
-6.88%
$16.22
AGNC
+1.29%
$10.18
NVO
-1.75%
$48.25
RR
-8.78%
$4.05
IONZ
+17.01%
$4.47
CGC
-5.83%
$1.12
DENN
+50.36%
$6.18
CTRA
+5.98%
$25.85
FUBO
+6.35%
$3.68
ETWO
0.00%
$3.30
META
-1.62%
$627.32

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.